Complex Regional Pain Syndrome: Medical Treatments
Commons · Question 106878 · Tabled 19 Jan 2026 · Department of Health and Social Care · Official record
Answered 26 Jan 2026
Question
Asked by Joshua Reynolds
To ask the Secretary of State for Health and Social Care, what the process is for evaluating new medical devices for the treatment of chronic neuropathic pain conditions for use in the NHS.
Answer
Answered by Zubir Ahmed, 26 Jan 2026
The Medicines and Healthcare products Regulatory Agency (MHRA) is responsible for ensuring that medicines, medical devices, and blood components for transfusions on the market in the United Kingdom are safe, effective, and manufactured to the highest stan...